The DTaP vaccine and why it should be avoided:
Five doses of the DTaP vaccine is recommended for children, given at ages 2 months, 4 months, 6 months, 15-18 months, and 5 years old.
DTaP is a trivalent vaccine, meaning 3 vaccines in 1 injection; Diphtheria, Tetanus and Acellular Pertussis.
Diphtheria is a bacteria transmitted through respiratory droplets. The toxin released by the bacteria can make a thick coating in the back of the nose or throat.
Symptoms: Weakness, sore throat, mild fever, swollen glands in neck…lasting 1-2 weeks.
Treatment: Antibiotics and/or Antitoxin. The antitoxin (DAT) is not licensed by the FDA in the US.
The disease is rarely seen in developed countries. From 1980-2010, only 55 cases have been reported to the CDC; 5 deaths.
Tetanus is a bacteria found in soil, dust and manure. It can produce a toxin in the body if it enters through a deep cut or puncture wound (made by a contaminated object) where there is little oxygen and/or no bleeding. The tetanus organism is anaerobic. It can not live in oxygen. Contrary to popular belief, tetanus has nothing to do with rust.
Symptoms: Headache, painful muscle stiffness, trouble swallowing, fever/sweating, high blood pressure, involuntary body jerking/staring.
Treatment: Tetanus Immune Globulin (TIG) antitoxin, Wound care, antibiotics, pharmaceuticals to control muscle spasms.
While it is recommended to get a tetanus vaccine after possible exposure, this will not be effective in combating the toxin. It takes the body weeks to develop sufficient antibodies to tetanus, which means the vaccine is not going to help. If you believe you have been exposed to tetanus, you will need the TIG antitoxin.
The CDC reports that there have been approximately 29 reported cases per year from 2001 through 2008; 26 deaths.
Pertussis (AKA Whooping cough) is a bacteria transmitted through respiratory droplets. The toxin released by the bacteria can cause airways to swell by damaging the cilia of the upper respiratory system.
Early Symptoms: Runny nose, low grade fever, mild, occasional cough, apnea in babies (pause in breathing)
Later Symptoms: Coughing fits, vomiting (after coughing fits), fatigue (after coughing fits)
Treatment: High dose vitamin C, antibiotics, cool mist vaporizer, plenty of fluids, reduction of air irritants
There were approximately 18,000 cases reported in 2015; 5 deaths. Infants aged less than 1 year are at greatest risk for complications and death.
The vaccine does not prevent transmission of the disease. It only suppresses symptoms. This means that a vaccinated person can be infected and spreading the illness without knowing it (for up to 6 weeks). According to the CDC, many babies who get pertussis are infected by older siblings, parents, or caregivers who have no symptoms and may not know they have the illness.
The vaccine efficacy rate is about 70-80% and wanes fairly quickly. The CDC has admitted that they have discovered that the bacteria has evolved and become vaccine-resistant, which is why we’re seeing outbreaks in vaccinated populations.
Vaccine ingredients include, but are not limited to: Aluminum, Polysorbate 80, Formaldehyde, 2-phenoxyethanol (anti-freeze), Thimerosal (mercury), cow milk protein
Vaccine Adverse Events: Bronchitis, Idiopathic thrombocytopenic (easy excessive bleeding), SIDS, anaphylactic reaction, cellulitis (skin infection), seizure/grand mal seizure, encephalopathy (brain swelling), hypotonia (low muscle tone), neuropathy (nerve damage), and apnea (pause in breathing).
Tripedia Package Insert – Lists autism as an adverse event, but is not used in the United States.
The Tripedia package insert states that Epinephrine injection must be immediately available should an acute anaphylactic reaction occur. The vaccine has not been evaluated for carcinogenic or mutagenic potential.
One study shows that 2/3rds of SIDS deaths occur within 3 weeks of receiving the DTap Vaccine. Apnea is a symptom of pertussis infection, as well as a reported reaction to the vaccine.
Children’s Health Defense – One in Nine Adverse Events Reported After DTaP Vaccination